We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. PCI improved angina symptoms at 12 weeks vs. a sham ...
PCI for coronary chronic total occlusion significantly improves angina symptom scores compared with placebo in patients with ...
LONG BEACH, California — Percutaneous coronary intervention procedures performed using the radial artery in the arm have almost tripled in the past decade, according to a new study evaluating 6.7 ...
NATICK, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, a leading developer of precision vascular robotics, announced today that the clinical trial of its CorPath® PRECISE (Percutaneous ...
Regulators are on board and the reimbursement is there, but should more complex percutaneous coronary intervention (PCI) procedures be shifted from a traditional hospital setting to an ambulatory ...
As the demand for cardiac care in the US continues to rise, and as more patients are screened and treated for cardiovascular disease, cardiac catheterization and percutaneous coronary intervention ...
Please provide your email address to receive an email when new articles are posted on . Registry data show transradial access was used for most patients who underwent complex, high-risk PCI.
Hosted on MSN
Drug-eluting balloon may be as safe, effective as conventional stents for repeat percutaneous coronary interventions
A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis (ISR) undergoing repeated percutaneous coronary intervention (PCI). These ...
SAN DIEGO, CA — Routine thrombectomy with PCI for acute ST-elevation MI (STEMI) does not confer an advantage in CV death, recurrent MI, shock, or severe heart failure over 6 months compared with ...
WALTHAM, Mass., Corindus Vascular Robotics, a leading developer of precision vascular robotics, announced today that the U.S. Food and Drug Administration has given 510(k) clearance for its ...
NATICK, Mass. Corindus Vascular Robotics, a leading developer of precision vascular robotics, announced today that the clinical trial of its CorPath® PRECISE (Percutaneous Robotic-Enhanced Coronary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results